Resmetirom and Bariatric Surgery: New Frontiers in Treating Obesity-Related Metabolic Dysfunction-Associated Steatohepatitis
Crossref DOI link: https://doi.org/10.1007/s11695-024-07430-y
Published Online: 2024-07-25
Published Print: 2024-09
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Au, Kahei
Yang, Wah
Text and Data Mining valid from 2024-07-25
Version of Record valid from 2024-07-25
Article History
Received: 8 July 2024
Revised: 17 July 2024
Accepted: 20 July 2024
First Online: 25 July 2024
Declarations
:
: Informed consent does not apply to this kind of study.
: The authors declare no competing interests.